NEW YORK (GenomeWeb) - Sysmex today announced that it has partnered with Singapore-based Clearbridge BioMedics to jointly develop a new liquid biopsy system.

The partners will utilize Clearbridge's microfluidics-based rare cell separation technology, with the goal of potentially creating a new product line to complement Sysmex's current suite of hematology analyzers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.